---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-019312"
form_type: "8-K"
ticker: "BEAT"
cik: "0001779372"
company_name: "HeartBeam, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:40:40.800330+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# HeartBeam launches $15M public offering; reports positive trial results for portable 12-lead ECG

## Summary
- $15M public offering of common stock; proceeds for clinical/reg ($2M), R&D ($7M), sales/mkt ($1M), G&A ($5M).
- HIDES study: VECG sensitivity 93%, specificity 95% vs cardiologist 70%/83% for early MI detection.
- First 510(k) submission for recording device in Q1 2023; second for synthesized 12-lead in Q4 2023; clearances expected in 12 months.
- Credit-card-sized device can replicate 12-lead ECG; holds foundational patents in portable VECG.
- Management includes CEO Branislav Vajdic, CFO Rick Brounstein; advisor panel includes key cardiologists.

## SEC filing metadata
- accession: 0001213900-23-019312
- form_type: 8-K
- ticker: BEAT
- cik: 0001779372
- company_name: HeartBeam, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779372/000121390023019312/0001213900-23-019312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779372/000121390023019312/ea174926-8k_heartbeam.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-019312
- JSON: https://secwatch.observer/filing/0001213900-23-019312.json
- Plain text: https://secwatch.observer/filing/0001213900-23-019312.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.